
QIAGEN N.V. QGEN
Geschäftsbericht 2025
hinzugefügt 18.04.2026
QIAGEN N.V. DIO 2011-2026 | QGEN
DIO Jährlich QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 141 | 132 | 117 | 116 | 108 | 101 | 110 | 101 | 96.1 | 115 | 115 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 141 | 96.1 | 114 |
DIO anderer Aktien in der Diagnostik & Forschung
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
97.1 | $ 116.01 | 0.41 % | $ 35.3 B | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
137 | $ 128.01 | 0.11 % | $ 20.4 B | ||
|
Co-Diagnostics
CODX
|
1.69 K | $ 1.66 | -0.4 % | $ 2.21 M | ||
|
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | ||
|
Lantheus Holdings
LNTH
|
40.4 | $ 84.39 | 0.07 % | $ 5.7 B | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
48.7 | $ 25.48 | 4.17 % | $ 708 M | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.62 | 0.55 % | $ 20 B | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 21.54 | 1.46 % | $ 1.15 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Senseonics Holdings
SENS
|
104 | $ 7.08 | 0.35 % | $ 295 M | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
Soleno Therapeutics
SLNO
|
1.02 K | $ 52.72 | - | $ 2.68 B | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 15.92 | -2.42 % | $ 481 M | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Thermo Fisher Scientific
TMO
|
86.5 | $ 468.84 | -0.16 % | $ 177 B | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
Trinity Biotech plc
TRIB
|
212 | $ 0.64 | -1.51 % | $ 61.9 M | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 173.7 | 2.3 % | $ 8.61 B | ||
|
Twist Bioscience Corporation
TWST
|
51.5 | $ 60.47 | -0.77 % | $ 3.62 B | ||
|
Guardant Health
GH
|
82.1 | $ 89.62 | 0.79 % | $ 11.2 B | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
29.1 | $ 1.91 | -3.29 % | $ 8.45 M | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
147 | $ 9.51 | -0.37 % | $ 2.06 B | ||
|
Biomerica
BMRA
|
147 | $ 2.16 | 0.93 % | $ 4.96 M | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 99.66 | -2.46 % | $ 8.22 B | ||
|
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 263.45 | -0.13 % | $ 21.9 B | ||
|
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
24.4 | $ 8.55 | 3.08 % | $ 1.1 B | ||
|
Myriad Genetics
MYGN
|
42.8 | $ 4.77 | -0.21 % | $ 442 M | ||
|
Natera
NTRA
|
25.8 | $ 205.15 | 0.69 % | $ 20.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 196.64 | 0.22 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
87.6 | - | -0.91 % | $ 14.7 B |